Difference between revisions of "Burtscher 2020 iScience"
(Created page with "{{Publication |title=Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience [Epub ahead of print]...") Β |
Β |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Publication | {{Publication | ||
|title=Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience | |title=Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience 23:101631. | ||
|info=[https://www.ncbi.nlm.nih.gov/pubmed/33015593 PMID: 33015593 Open Access] | |info=[https://www.ncbi.nlm.nih.gov/pubmed/33015593 PMID: 33015593 Open Access] | ||
|authors=Burtscher | |authors=Burtscher Johannes, Cappellano Giuseppe, Omori Akiko, Koshiba Takumi, Millet Gregoire P | ||
|year=2020 | |year=2020 | ||
|journal=iScience | |journal=iScience | ||
Line 9: | Line 9: | ||
<small>Β© 2020 The Author(s). </small> | <small>Β© 2020 The Author(s). </small> | ||
|editor=[[Plangger M]] | |editor=[[Plangger M]] | ||
|mipnetlab=CH Lausanne Place N | |||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area= | |area=mt-Medicine | ||
| | |diseases=Infectious | ||
|additional=2020-10 | |additional=2020-10 | ||
}} | }} |
Latest revision as of 22:42, 29 October 2020
Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience 23:101631. |
Burtscher Johannes, Cappellano Giuseppe, Omori Akiko, Koshiba Takumi, Millet Gregoire P (2020) iScience
Abstract: The pathophysiology, immune reaction, differential vulnerability of different population groups and viral host immune system evasion strategies of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection are not yet well understood. Here, we reviewed the multitude of known strategies of coronaviruses and other viruses to usurp mitochondria-associated mechanisms involved in the host innate immune response and put them in context with the current knowledge on SARS-CoV-2. We argue that maintenance of mitochondrial integrity is essential for adequate innate immune system responses and to blunt mitochondrial modulation by SARS-CoV-2. Mitochondrial health thus may determine differential vulnerabilities to SARS-CoV-2 infection rendering markers of mitochondrial functions promising potential biomarkers for SARS-CoV-2 infection risk and severity of outcome. Current knowledge gaps on our understanding of mitochondrial involvement in SARS-CoV-2 infection, life-style and pharmacological strategies to improve mitochondrial integrity and potential reciprocal interactions with chronic and age-related diseases, e.g. Parkinson's Disease, are pointed out.
Β© 2020 The Author(s).
β’ Bioblast editor: Plangger M β’ O2k-Network Lab: CH Lausanne Place N
Labels: MiParea: mt-Medicine
Pathology: Infectious
2020-10